Abstract
1 Clonidine kinetics were studied in 21 patients with essential hypertension. All received two bolus i.v. injections in the mean dose range of (0.78--3.36 micrograms kg-1) and one single oral dose (mean dose 1.7--2.3 micrograms kg-1) on separate occasions. The kinetics were also studied in some of these patients after multiple therapeutic oral dose (mean dose 1.1 or 1.9 micrograms kg-1) twice daily during a dosage interval after 6--12 months monotherapy with clonidine. The multiple oral dosage was based on the therapeutic response. 2 With increasing i.v. doses the rate constants (alpha, beta) decreased and the plasma clearance was reduced by 74% (9.94--2.61 ml min-1 kg-1) indicating dose-dependent kinetics. The volume of distribution (Vd beta) did not change with dose in contrast to the volume of the plasma compartment (Vc) which was increased at the highest doses. 3 The single oral dose kinetics agreed with the i.v. kinetics at comparable dose. The bioavailability was 90%. 4 During multiple oral dosing the elimination rate constants decreased compared to the single dose. The plasma clearance increased (7.18 ml min-1 kg-1) compared to the corresponding single dose (4.17 ml min-1 kg-1). The latter change was probably caused by the decrease in bioavailability to about 65%. 5 The pharmacodynamic properties of the drug could explain the changes in pharmacokinetics with increased dose and during multiple doses.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Boudier H. S., de Boer J., Smeets G., Lien E. J., van Rossum J. Structure activity relationships for central and peripheral alpha adrenergic activities of imidazoline derivatives. Life Sci. 1975 Aug 1;17(3):377–385. doi: 10.1016/0024-3205(75)90487-7. [DOI] [PubMed] [Google Scholar]
- Darda S., Förster H. J., Sthle H. Metabolischer Abbau von Clonidin. Arzneimittelforschung. 1978;28(2):255–259. [PubMed] [Google Scholar]
- Dollery C. T., Davies D. S., Draffan G. H., Dargie H. J., Dean C. R., Reid J. L., Clare R. A., Murray S. Clinical pharmacology and pharmacokinetics of clonidine. Clin Pharmacol Ther. 1976 Jan;19(1):11–17. doi: 10.1002/cpt197619111. [DOI] [PubMed] [Google Scholar]
- Edlund P. O. Determination of clonidine in human plasma by glass capillary gas chromatography with electron-capture detection. J Chromatogr. 1980 Jan 4;187(1):161–169. doi: 10.1016/s0021-9673(00)87882-6. [DOI] [PubMed] [Google Scholar]
- Frisk-Holmberg M., Edlund P. O., Paalzow L. Pharmacokinetics of clonidine and its relation to the hypotensive effect in patients. Br J Clin Pharmacol. 1978 Sep;6(3):227–232. doi: 10.1111/j.1365-2125.1978.tb04589.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Paalzow L. K., Edlund P. O. Pharmacokinetics of clonidine in the rat and cat. J Pharmacokinet Biopharm. 1979 Oct;7(5):481–494. doi: 10.1007/BF01062390. [DOI] [PubMed] [Google Scholar]
- Rehbinder D., Deckers W. Untersuchungen zur Pharmakokinetik und zum Metabolismus des 2-(2,6-Dichlorphenylamino)-2-imidazolin-hydrochlorid (St 155) Arzneimittelforschung. 1969 Feb;19(2):169–176. [PubMed] [Google Scholar]
- Ruwart M. J., Klepper M. S., Rush B. D. Clonidine delays small intestinal transit in the rat. J Pharmacol Exp Ther. 1980 Mar;212(3):487–490. [PubMed] [Google Scholar]
- Wing L. M., Reid J. L., Davies D. S., Neill E. A., Tippett P., Dollery C. T. Pharmacokinetic and concentration-effect relationships of clonidine in essential hypertension. Eur J Clin Pharmacol. 1977 Dec 28;12(6):463–469. doi: 10.1007/BF00561067. [DOI] [PubMed] [Google Scholar]